NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Go back to NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic
NEOGENOMICS (NASDAQ: NEO) Delayed: 19.75 -0.16 (0.8%)
Previous Close $19.91    52 Week High $9.54 
Open $19.92    52 Week Low $5.49 
Day High $20.05    P/E 493.75 
Day Low $19.65    EPS $0.04 
Volume 121,564